Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate changes in adrenal hormones during adrenal radiofrequency (RF) ablation.
Adrenal radiofrequency (RF) ablation has been increasingly used for the treatment of unresectable adrenal tumors. But one of the major complication is a increase in blood pressure. Hormonal release during RF ablation is considered the cause of hypertension. But there has been no evidence that adrenal hormones affects changes in blood pressure. In this prospective study, we evaluate the changes in adrenal hormones during RF ablation and clarify the cause of hypertensive crisis.
Age
20 - No limit years
Sex
ALL
Healthy Volunteers
No
Mie University Hospital
Tsu, Mie-ken, Japan
Mie University
Tsu, Mie-ken, Japan
Start Date
October 1, 2009
Primary Completion Date
October 1, 2010
Completion Date
October 1, 2010
Last Updated
April 28, 2015
18
ACTUAL participants
Radiofrequency ablation
PROCEDURE
Lead Sponsor
Mie University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions